跳至主要内容
临床试验/NCT01679522
NCT01679522已完成不适用

Prospective Randomized Comparison of Single-port and Four-port Laparoscopic Staging Operation for Endometrial Cancer

Asan Medical Center2 个研究点 分布在 1 个国家目标入组 107 人开始时间: 2013年1月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
107
试验地点
2
主要终点
operating time

研究概览

简要总结

To compare the feasibility, safety, and efficacy between single-port and four-port laparoscopic surgical staging in patients with early stage endometrial cancer.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
20 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Previously untreated, histologically confirmed endometrial cancer
  • Presumed FIGO stage 1
  • Endometrioid adenocarcinoma
  • patient who is planned to undergo surgical staging
  • adequate oran function
  • WBC > 3000 cells/mcl
  • Platelets > 100000/mcl
  • Creatinine < 2.0 mg/dL
  • Bilirubin < 1.5 * normal and SGOT or SGPT < 3 * normal
  • American Society of Anesthesiologists Physical Status I-II
  • Eastern Cooperative Oncology Group performance status 0-2
  • Patients who have signed an approved Informed Consent

排除标准

  • Uncontrolled medical disease
  • Active infectious disease requiring antibiotics
  • Previous pelvic radiation therapy
  • Pregnant and lactating woman
  • Patient who requires additional surgical procedures which are not necessary for surgical staging of endometrial cancer

结局指标

主要结局

operating time

时间窗: 1 day (Immediately after operation)

Total operation time and time required for each procedure are calculated and compared.

Number of lymph nodes retrieved

时间窗: 1 week after surgery

The number of right pelvic lymph nodes and left pelvic lymph nodes were obtained and compared.

次要结局

  • transfusion requirement and amount(within 1 week after surgery)
  • Postoperative pain(within 1 week after surgery)
  • Postoperative analgesics requirement(within 1 week after surgery)
  • postoperative complications(within 1 month after surgery)
  • recurrence free survival(34 months after surgery)
  • overall survival(34 months after surgery)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Joo-Hyun Nam

Professor

Asan Medical Center

研究点 (2)

Loading locations...

相似试验